News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Perros Manoussos
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 87,462 options to buy
@ $4.98, valued at
$435.6k
Granted 58,307 options to buy
@ $2.44, valued at
$142.3k
Disposed/sold 166,623 options to buy
@ $6.85, valued at
$1.1M
Granted 128,531 options to buy
@ $2.44, valued at
$313.6k
Disposed/sold 79,698 options to buy
@ $15, valued at
$1.2M
Granted 44,276 options to buy
@ $2.44, valued at
$108k
Disposed/sold 123,500 options to buy
@ $5.66, valued at
$699k
Granted 95,000 options to buy
@ $2.44, valued at
$231.8k
|
|
| 01/19/2022 |
4
| Perros Manoussos (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 11/03/2021 |
4
| Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Paid exercise price by delivering 11,704 shares
@ $2.94, valued at
$34.4k
|
|
| 10/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2020 |
4
| Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 145,000 options to buy
@ $4.94, valued at
$716.3k
|
|
| 01/22/2019 |
4
| Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 123,500 options to buy
@ $5.66, valued at
$699k
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2018 |
3
| Perros Manoussos (President and CEO) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
|
|